1-(4-Bromophenyl)-4-methylpiperazine - CAS 130307-08-3
Catalog: |
BB007079 |
Product Name: |
1-(4-Bromophenyl)-4-methylpiperazine |
CAS: |
130307-08-3 |
Synonyms: |
1-(4-bromophenyl)-4-methylpiperazine; 1-(4-bromophenyl)-4-methylpiperazine |
IUPAC Name: | 1-(4-bromophenyl)-4-methylpiperazine |
Description: | 1-(4-Bromophenyl)-4-methylpiperazine (CAS# 130307-08-3) is a useful research chemical. |
Molecular Weight: | 255.15 |
Molecular Formula: | C11H15BrN2 |
Canonical SMILES: | CN1CCN(CC1)C2=CC=C(C=C2)Br |
InChI: | InChI=1S/C11H15BrN2/c1-13-6-8-14(9-7-13)11-4-2-10(12)3-5-11/h2-5H,6-9H2,1H3 |
InChI Key: | WCOODAWUEIXTFL-UHFFFAOYSA-N |
Boiling Point: | 331 °C at 760 mmHg |
Density: | 1.35 g/cm3 |
Appearance: | White to beige to brown powder |
LogP: | 2.20380 |
Publication Number | Title | Priority Date |
WO-2020257487-A1 | Glycolate oxidase inhibitors for the treatment of disease | 20190619 |
WO-2020016243-A1 | Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death | 20180716 |
WO-2019233883-A1 | Tetrahydrobenzofuro[2,3-c]pyridine and beta-carboline compounds for the treatment, alleviation or prevention of disorders associated with tau aggregates | 20180604 |
US-2021267989-A1 | Novel Compounds for the Treatment, Alleviation or Prevention of Disorders Associated with Tau Aggregates | 20180604 |
EP-3736266-A1 | Compound simultaneously inhibiting lsd1 and hdac targets and application thereof | 20180104 |
Complexity: | 170 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 254.04186 |
Formal Charge: | 0 |
Heavy Atom Count: | 14 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 254.04186 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 6.5 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.5 |
-
Catalog: BB078843
(2R,5R)-1,2,5-trimethylpiperazine dihydrochloride
Detail
-
Catalog: BB078849
((2S,4S)-1-benzyl-4-((tert-butyldimethylsilyl)oxy)pyrrolidin-2-yl)methanol
Detail
-
Catalog: BB077946
(2S,5R)-5-Ethyl-2-methyl-1-tosylpiperazine
Detail
-
Catalog: BB078864
((2R,5R)-5-methylpiperazin-2-yl)methanol dihydrochloride
Detail
-
Catalog: BB021304
(3S)-1-benzyl-3-(propan-2-yl)piperazine
Detail
-
Catalog: BB079235
(2R,5R)-tert-Butyl 5-(hydroxymethyl)-2-methylpiperazine-1-carboxylate
Detail
-
Catalog: BB000557
((1-[(4-Methyl-1-piperazinyl)methyl]cyclopropyl)methyl)amine
Detail
-
Catalog: BB079202
(2R,5R)-1,2,5-Trimethylpiperazine
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Piperazines
Customers Also Viewed
-
[1263166-91-1]
endo-BCN-PNP-carbonate
-
[91054-33-0]
2-acetylbenzenecarbonitrile
-
[75726-96-4]
2-Bromo-N-isopropylacetamide
-
[1393527-23-5]
Phosphoric acid 6,6'-di(9-anthryl)-1,1'-spirobiindan-7,7'-diyl ester
-
[1314965-08-6]
2-Oxa-8-azaspiro[4.5]decan-1-one hydrochloride
-
[1388152-02-0]
1,2-Cyclopentanediol, 3-amino-5-[(phosphonooxy)methy]-, ammonium salt (1:2), (1R,2S,3R,5R)-
INDUSTRY LEADERS TRUST OUR PRODUCTS